Stevens Capital Management’s Progenics Pharmaceuticals Inc PGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-14,271
| Closed | -$85K | – | 1078 |
|
|
2017
Q4 | $85K | Buy |
+14,271
| New | +$85K | ﹤0.01% | 776 |
|
|
2017
Q3 | – | Sell |
-54,771
| Closed | -$372K | – | 1149 |
|
|
2017
Q2 | $372K | Buy |
54,771
+1,231
| +2% | +$8.36K | 0.01% | 635 |
|
|
2017
Q1 | $505K | Buy |
+53,540
| New | +$505K | 0.02% | 576 |
|
|
2016
Q1 | – | Sell |
-10,602
| Closed | -$65K | – | 1192 |
|
|
2015
Q4 | $65K | Buy |
+10,602
| New | +$65K | ﹤0.01% | 873 |
|
|
2015
Q2 | – | Sell |
-18,431
| Closed | -$110K | – | 1322 |
|
|
2015
Q1 | $110K | Buy |
+18,431
| New | +$110K | ﹤0.01% | 918 |
|
|
2014
Q2 | – | Sell |
-21,262
| Closed | -$87K | – | 1393 |
|
|
2014
Q1 | $87K | Buy |
+21,262
| New | +$87K | ﹤0.01% | 1013 |
|
|
2013
Q4 | – | Sell |
-19,785
| Closed | -$99K | – | 1319 |
|
|
2013
Q3 | $99K | Buy |
+19,785
| New | +$99K | ﹤0.01% | 973 |
|